Enovis Introduces STAR Ankle, Now With E+ Polyethylene for Unmatched Durability
Enovis Introduces STAR Ankle, Now With E+ Polyethylene for Unmatched Durability
Revolutionary Scandinavian Total Ankle Replacement (STAR Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert
革命性的斯堪的纳维亚全踝关节置换(STAR踝关节)系统现已包含维生素E混合聚乙烯插入
STAR Ankle with e+ Polyethylene
科创板e+聚乙烯材质脚踝支撑
Wilmington, DE, Aug. 19, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology company, proudly unveils its Scandinavian Total Ankle Replacement (STAR Ankle), now with new e+ Polyethylene. Recent U.S. Food and Drug Administration (FDA) approval makes STAR Ankle the first and only mobile bearing ankle system with e+ Polyethylene in the United States.1 The implant's new vitamin E-blended e+ Polyethylene insert will offer improved durability, stability, and longevity.1
2024年8月19日,特拉华州威明顿(GLOBE NEWSWIRE)——创新驱动的医疗技术公司Enovis Corporation(纽交所代码:ENOV)骄傲地推出了其斯堪的纳维亚全踝关节置换(STAR踝关节),现已采用新的e+聚乙烯。美国食品和药物管理局(FDA)的最新批准使STAR踝关节成为美国第一个也是唯一一个搭载e+聚乙烯的移动轴承踝关节系统。1该植入物的新型维生素E混合e+聚乙烯插入物将提供更好的耐久性、稳定性和寿命。
"With e+ Polyethylene, we uphold our commitment to the advancement of our total ankle portfolio, merging full oxidative resistance with the time-tested design of the STAR Ankle," said Gary Justak, President and General Manager of Enovis Foot & Ankle. "Building upon the proven success of the STAR Ankle epitomizes our culture of advancing foot and ankle solutions and elevating patient treatment options. We don't just set the standard—we redefine it."
“采用e+聚乙烯,我们不断推进我们的全踝关节组合产品系列的先进性,将全新的抗氧化性能与经过时间检验的STAR踝关节设计相结合,”Enovis Foot&Ankle总裁兼总经理Gary Justak说道,“在证明STAR踝关节的优异效果之上,我们推动了足踝解决方案不断进步和提高患者治疗选择的文化。我们不只是设置标准,我们重新定义它。”
e+ Polyethylene contains the free radical-neutralizing antioxidant vitamin E; as a result, the material resists oxidation and maintains consistent wear rates and stable mechanical properties over time. In contrast, other highly crosslinked polyethylenes are remelted during manufacturing to neutralize free radicals2, a process that can reduce their mechanical strength by up to 12%.1,3
e+聚乙烯含有自由基中和抗氧化剂维生素E;因此,该材料抵御氧化,保持一致的磨损率和稳定的机械性能。相比之下,其他高度交联的聚乙烯在制造过程中被重新熔融,以中和自由基2,该过程可能会将其机械强度降低高达12%。1,3
"After extensive clinical experience with this superior material in knee and shoulder implants, along with years of laboratory testing, I expect improved patient outcomes through increased polyethylene longevity. This builds on the outstanding STAR Ankle long-term metal-component survival rates seen in multiple clinical studies," stated Dr. Gregory Lundeen, a foot and ankle orthopedic surgeon at Reno Orthopedic Center.
“经过对该卓越材料在膝盖和肩膀植入物上的广泛临床经验以及多年实验室测试,我希望通过增加聚乙烯寿命来改善患者的效果。这在多项临床研究中看到了STAR踝关节长期金属部件存活率的杰出成果,”Reno Orthopedic Center的足踝骨科医生Gregory Lundeen博士表示。
Combined with the recent release of STAR Patient Specific Instrumentation (PSI), the STAR+ Experience represents Enovis' commitment to continuous improvement, aimed at enhancing patient satisfaction and outcomes. The integration of e+ Polyethylene in the STAR Ankle continues to enhance the remarkable success of this implant, which has been used globally over 40,000 times across its 37-year history.4
加上最近推出的STAR患者特异性仪器(PSI),STAR+体验表明Enovis致力于不断改进,旨在增强患者的满意度和结果。将e+聚乙烯集成到STAR踝关节中,继续提高这种植入物的显著成功,该植入物在其37年的历史中已在全球使用超过40000次。4
For more information about the STAR Ankle with e+ Polyethylene and Enovis' innovative foot and ankle solutions, please visit .
有关搭载e+聚乙烯的STAR踝关节和Enovis创新的足踝解决方案的更多信息,请访问 .
Individual results may vary. Neither Enovis Corporation nor any of its subsidiaries dispense medical advice. The contents of this release do not constitute medical, legal, or any other type of professional advice. Rather, please consult your healthcare professional for information on the courses of treatment, if any, which may be appropriate for you.
个人结果可能有所不同。Enovis Corporation及其附属公司不提供医疗建议。本文不构成医学、法律或任何其他类型的专业建议。请咨询您的医疗保健专业人员,以获取有关适合您的治疗方案及其它方面的信息。
Dr. Gregory Lundeen is a consultant for Enovis Corporation.
Gregory Lundeen博士是Enovis Corporation的顾问。
References
参考
- e+ testing data on file. Bench test results not necessarily indicative of clinical performance.
- Jennings et al. The influence of femoral condylar lift-off on the wear of artificial knee joints. Proc Inst Mech Eng [H]. 2007 Apr;221(3):305-14.
- S.M. Kurtz. "The UHMWPE Handbook: Ultra-high Molecular Weight Polyethylene in Total Joint Replacement". Elsevier Academic Press, 2009.
- Enovis internal document: Includes world-wide implantations of all generations; newest generation has over 40,000 world-wide from 1998-2022
- 文件中包含的e+测试数据。台架测试结果不一定能反映临床性能。
- 詹宁斯等人。股骨髁脱离对人工膝关节磨损的影响。机械工程师协会会议讲稿[H]。2007年4月;221(3):305-14。
- S.m. Kurtz. “UHMWPE手册:超高分子量聚乙烯全关节置换”。Elsevier Academic Press,2009。
- Enovis内部文件:包括所有世代的全球植入;最新一代的全球范围内已经使用了超过40,000次,时间是1998-2022年。
About Enovis
关于Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit .
Enovis Corporation(纽交所代码:ENOV)是一家创新驱动的医疗技术增长公司,致力于开发产生可测量更好患者结果和转换工作流程的临床差异化解决方案。在不断改进、全球人才和创新的文化推动下,公司广泛的产品、服务和综合技术范围推动骨科和其他领域的积极生活方式。有关Enovis的更多信息,请访问 .
Media Contact
媒体联系人
Diana Aldermae
Diana Aldermae
Enovis Foot & Ankle
Enovis Foot&Ankle
Diana.Aldermae@enovis.com
Diana.Aldermae@enovis.com
MK-10554
Mk-10554
Attachment
附件
- STAR Ankle with e+ Polyethylene
- 科创板e+聚乙烯材质脚踝支撑